Mary K. Caffrey | Authors


A New Concept to Broaden Access to Molecular Testing

August 06, 2014

During a 2013 discussion on treating NSCLC, a group of oncologists were asked what share of cancer patients have access to molecular testing. The answers varied: One said he guessed 40% to 50%, another said "a large minority."